Seegene Arab League
상단으로
اتصل بنا

أخبار المنتج يمكنك التحقق من أحدث معلومات المنتج

  • Launched Seeplex® UTI ACE Detection, Seeplex® MRSA ACE Detection, and Seeplex® GBS-R ACE Detection.

    Seeplex® UTI ACE Detection Detection of bacteria causing urinary tract infection   Launched Seeplex® UTI ACE Detection Seeplex® MRSA ACE Detection Detection of MRSA (methicillin resistant Staphylococcus aureus)  Launched Seeplex® MRSA ACE Detection Seeplex®  GBS-R ACE Detection Detections of GBS and erythromycin/clindamycin resistant genes Launched Seeplex® GBS-R ACE Detection.

    Jun 01, 2009｜ Seeplex® UTI ACE Detection , Seeplex® MRSA ACE Detection , Seeplex® GBS-R ACE Detection

  • Launched Seeplex® STI Master ACE Detection

    Seeplex® STI Master ACE Detection Total solution for the detection of pathogens causing STDs The conventional methods (ELISA, Giemsa stain, culture, etc.) to detect STI pathogens take several days or suffer from poor sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's STI Master ACE Detection is outstanding in terms of sensitivity and specificity using a novel DPO technology and currently detects the largest number of pathogens causing sexually transmitted infections.

    May 01, 2009｜ Seeplex® STI Master ACE Detection

  • Obtained CE-IVD marking for Seeplex® HPV6 ACE Genotyping

    Seeplex® HPV6 ACE Genotyping                                                                                Seegene's Seeplex® CMV ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Mar 03, 2009｜ Seeplex® HPV6 ACE Detection

  • Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection

    Simultaneous detection of 12 major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection

    Nov 04, 2008｜ Seeplex® RV12 ACE Detection

  • Received Approval from Health Canada for Seepelx® RV5 ACE Screening...

    Seeplex® RV5 ACE Screening Rapid screening of most prevalent respiratory viruses Seeplex® RV5 ACE Screening has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.NOT AVAILABLE IN US Seeplex® RV 12 ACE Detection Simultaneously detection 12 major respiratory viruses Seeplex® RV 12 ACE Detection has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.

    Nov 03, 2008｜ Seeplex® RV12 ACE Detection , Seeplex® RV5 ACE Screening

  • Launched Seeplex® HPV6 ACE Detection

    Seeplex® HPV6 ACE Detection   Launched Seeplex® HPV6 ACE Detection

    Oct 01, 2008｜ Seeplex® HPV6 ACE Detection

  • Obtained CE-IVD marking for Seeplex® HPV18 ASE Genotyping

    Seeplex® HPV18 ASE Genotyping Seegene's Seeplex® HPV18 ASE Genotyping has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Jul 31, 2008｜ Seeplex® HPV18 ASE Genotyping

  • Obtained CE-IVD marking for Seeplex® STD6 ACE Detection

    Seegene's Seeplex® STD6 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union. 

    Jul 21, 2008｜ Seeplex® STD6 ACE Detection

1112131415